Targeting epigenetic mechanisms as an emerging therapeutic strategy in pulmonary hypertension disease

Pulmonary arterial hypertension (PAH) is a multifactorial cardiopulmonary disease characterized by an elevation of pulmonary artery pressure (PAP) and pulmonary vascular resistance (PVR), which can lead to right ventricular (RV) failure, multi-organ dysfunction, and ultimately to premature death. De...

Descripción completa

Detalles Bibliográficos
Autores principales: Bisserier, Malik, Janostiak, Radoslav, Lezoualc’h, Frank, Hadri, Lahouaria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065685/
https://www.ncbi.nlm.nih.gov/pubmed/32161845
http://dx.doi.org/10.1530/VB-19-0030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065685/
https://www.ncbi.nlm.nih.gov/pubmed/32161845
http://dx.doi.org/10.1530/VB-19-0030

Ejemplares similares